Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by RetailRubeon Sep 22, 2014 2:38pm
271 Views
Post# 22959139

Debt Outstanding as at Sept-15-2014

Debt Outstanding as at Sept-15-2014Look at Schedule B of the Agency Agreement between Dundee and Bioniche.  It contains an itemized list of debt outstanding as at Sept 15.  This is not in the prospectus, which contains only a March 31 pro-forma balance sheet which rolls through the sale of the Animal Health business.

Debt outstanding on the VMC is now just under $10 million.

Unless they make a payment on any of this debt between now and Sept 30th, this is the picture you will see when they publish their Sept 30th Q1 financial statements, normally released at the AGM in November.


<< Previous
Bullboard Posts
Next >>